Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.

@article{Petersen2016RisksAB,
  title={Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.},
  author={Irene Petersen and Rachel L. McCrea and Cormac J. Sammon and David Pj Osborn and Stephen Jw Evans and Phillip J. Cowen and Nick Freemantle and Irwin Nazareth},
  journal={Health technology assessment},
  year={2016},
  volume={20 23},
  pages={
          1-176
        }
}
BACKGROUND Although many women treated with psychotropic medication become pregnant, no psychotropic medication has been licensed for use in pregnancy. This leaves women and their health-care professionals in a treatment dilemma, as they need to balance the health of the woman with that of the unborn child. The aim of this project was to investigate the risks and benefits of psychotropic medication in women treated for psychosis who become pregnant. OBJECTIVE(S) (1) To provide a descriptive… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 116 REFERENCES

Clinical Management and Service Guidance

National Institute for Health, Care Excellence. Antenatal, Postnatal Mental Health
  • London: NICE; 2014. URL: www.nice.org.uk/guidance/ cg192
  • 2015
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.

  • Archives of disease in childhood. Education and practice edition
  • 2014
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Increasing use of atypical antipsychotics and anticonvulsants during pregnancy.

  • Pharmacoepidemiology and drug safety
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Maternal use of antipsychotics in early pregnancy and delivery outcome.

  • Journal of clinical psychopharmacology
  • 2008
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Teratogenic effects of antiepileptic drugs

  • The Lancet Neurology
  • 2008
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers